- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterSaturday, November 5, 2005
New Perspectives in Oncology Practice - This full day program for oncology nurses, NPs, PAs, and others involved in oncology care, took place following the Chemotherapy Foundation Symposium (also known as The Greenspan Meeting, named for its founder, Dr. Ezra Greenspan). The day was packed with a variety of speakers, covering all areas of oncology care. The following are summaries of a selected few of among the sessions presented. Meeting highlights will be posted on the Foundation's website, as will information about next year's conference: http://www.mssm.edu/tcf/. |
|
Hormonal Therapies in Breast Cancer
Maureen Major , MS , RN from Memorial Sloan-Kettering Cancer Center started the morning by updating the group on the latest studies in hormonal therapies for the treatment of early stage breast cancer. There are approximately 215,900 cases of... |
|
|
Pancreatic Cancer: Progress on the Horizon
Presented by: Shannon Holloway, MHS , PA -C, New York Presbyterian Weill Cornell Medical Center Pancreatic cancer accounts for 30,500 new cases annually, with a dismal 5-year survival rate of 15% when respectable, down to 1.8% when distant... |
|
|
Relative Dose Intensity: Improving Cancer Treatment and Outcomes
Presented by: Cheryl Lenhart, RN, BSN, HRM, Western Pennsylvania Cancer Institute, West Penn Allegheny Health System Relative dose intensity is a term that refers to the amount of a particular chemotherapy given over a specific time (i.e.... |
|
|
Trastuzumab Adjuvant Therapy in Breast Cancer: Bringing the Promise of Clinical Results to Patients
Presented by: Tamsin Mulrooney, PhD(c), MS, ARNP, OCN, Norris Cotton Cancer Center at Dartmouth Hitchcock Medical Center Tammy presented the data, recently discussed at ASCO 2005 and published in the New England Journal of Medicine, that many... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
